Predictive Oncology Correlations

POAIDelisted Stock

USD 5.95 0.00 0.00%

The correlation of Predictive Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Predictive Oncology Correlation With Market

Pay attention - limited upside

The correlation between Predictive Oncology and DJI is -0.84 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with Predictive Stock

0.73

HPQ

HP Inc

Pair Corr

Moving against Predictive Stock

0.91	AA	Alcoa Corp	Pair Corr
0.87	WMT	Walmart Common Stock Aggressive Push	Pair Corr
0.86	MRK	Merck Company Earnings Call Today	Pair Corr
0.82	BA	Boeing	Pair Corr
0.8	JNJ	Johnson Johnson	Pair Corr
0.71	XOM	Exxon Mobil Corp Aggressive Push	Pair Corr
0.68	TLKMF	Telkom Indonesia Tbk	Pair Corr
0.64	GNTX	Gentex	Pair Corr
0.58	EC	Ecopetrol SA ADR	Pair Corr
0.56	CVX	Chevron Corp	Pair Corr
0.55	MCD	McDonalds	Pair Corr
0.54	INTC	Intel Aggressive Push	Pair Corr
0.53	PTAIY	Astra International Tbk	Pair Corr
0.45	TLK	Telkom Indonesia Tbk	Pair Corr
0.43	CSCO	Cisco Systems Earnings Call This Week	Pair Corr
0.37	JPM	JPMorgan Chase	Pair Corr
0.33	AXP	American Express	Pair Corr
0.31	GE	GE Aerospace	Pair Corr

Related Correlations Analysis

	MYNZ	BNGO	VYNE	KTTA	GBS	TCRT	HSCS	CYCN	AIM	AMIX
MYNZ		0.19	-0.27	-0.33	0.0	-0.62	0.32	0.45	0.64	0.23	MYNZ
BNGO	0.19		-0.55	0.05	0.0	0.02	-0.29	0.64	0.7	0.7	BNGO
VYNE	-0.27	-0.55		0.36	0.0	-0.02	0.38	-0.42	-0.61	-0.88	VYNE
KTTA	-0.33	0.05	0.36		0.0	0.49	-0.25	-0.09	-0.24	-0.28	KTTA
GBS	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	GBS
TCRT	-0.62	0.02	-0.02	0.49	0.0		-0.55	-0.1	-0.26	0.03	TCRT
HSCS	0.32	-0.29	0.38	-0.25	0.0	-0.55		-0.12	-0.15	-0.46	HSCS
CYCN	0.45	0.64	-0.42	-0.09	0.0	-0.1	-0.12		0.7	0.43	CYCN
AIM	0.64	0.7	-0.61	-0.24	0.0	-0.26	-0.15	0.7		0.7	AIM
AMIX	0.23	0.7	-0.88	-0.28	0.0	0.03	-0.46	0.43	0.7		AMIX
	MYNZ	BNGO	VYNE	KTTA	GBS	TCRT	HSCS	CYCN	AIM	AMIX

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AIM	+ 0.7	BNGO
AMIX	+ 0.7	BNGO
AIM	+ 0.7	CYCN
AMIX	+ 0.7	AIM
AIM	+ 0.64	MYNZ
CYCN	+ 0.64	BNGO

High negative correlations

AMIX	- 0.88	VYNE
TCRT	- 0.62	MYNZ
AIM	- 0.61	VYNE
HSCS	- 0.55	TCRT
VYNE	- 0.55	BNGO
AMIX	- 0.46	HSCS

Risk-Adjusted Indicators

There is a big difference between Predictive Stock performing well and Predictive Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Predictive Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MYNZ	4.15	(0.34)	0.00	(1.18)	0.00	0.00	9.48	(6.67)	21.62
BNGO	2.50	(0.63)	0.00	(0.25)	0.00	0.00	4.61	(5.56)	21.29
VYNE	3.20	0.94	0.23	(1.85)	2.35	(5.53)	5.71	(5.26)	55.08
KTTA	7.77	1.23	0.14	0.44	7.54	(12.42)	16.67	(12.50)	137.41
GBS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TCRT	4.39	0.13	0.02	0.15	5.46	(4.87)	9.61	(10.55)	24.31
HSCS	4.25	0.17	0.02	(1.91)	5.04	(5.01)	11.07	(6.48)	26.18
CYCN	4.57	(0.43)	0.00	(0.21)	0.00	0.00	11.11	(10.56)	55.81
AIM	4.37	(1.10)	0.00	(0.29)	0.00	0.00	7.69	(10.32)	29.72
AMIX	5.11	(1.21)	0.00	9.33	0.00	0.00	7.50	(11.93)	74.93

Delisting Warning - POAI

Predictive Oncology was delisted

The entity Predictive Oncology with a symbol POAI was delisted from NASDAQ Exchange. Please try Axe Compute with a symbol AGPU from now on. Check all delisted instruments accross multiple markets.

Predictive Oncology Corporate Management

Joshua MBA	Interim Officer	Profile
BS BSc	VP RD	Profile
Pamela MBA	Chief Officer	Profile
Thomas McLaughlin	Chief Officer	Profile
Sara JD	Senior Counsel	Profile
Raymond Vennare	CEO Chairman	Profile

Still Interested in Predictive Oncology?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC